ACS Nano · 7 Nov 2026
Self-Dissociating Albumin Nanoclusters for Passive Lymph Node-Targeted Inverse Vaccination in a Rheumatoid Arthritis Model
Min-Jae Kim, Yina Wu, Na-Young Yu, Pil-Jae Song, Gyulim Kim, Dahan Kim, Voradanu Visetvichaporn, Nae-Won Kang, Yu-Kyoung Oh, Dae-Duk Kimh-index 11
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Engineering lymph node-targeted tolerogenic nanomaterials requires simultaneous antigen–drug coloading and efficient lymphatic transport. However, conventional biocompatible nanoparticles with static architectures often face a size-dependent trade-off: larger particles enable cargo coloading but drain inefficiently to lymph nodes, whereas smaller particles favor lymphatic transport but have limited cargo versatility. Here, a size-transformable, self-dissociating albumin nanocluster inverse vaccine is introduced to address this materials design trade-off. Citrullinated peptide antigens are conjugated to human serum albumin, and rapamycin (RAPA) is coloaded using ball-milling technology to generate 200–300 nm nanoclusters. After subcutaneous injection, the nanoclusters dissociate into sub-10 nm albumin-based units, enabling passive lymphatic transport and accumulation in draining lymph nodes while maintaining coordinated antigen–RAPA codelivery. In vitro mechanistic studies show that the nanoclusters induce a tolerogenic dendritic cell phenotype and promote antigen-specific immune regulation. In a collagen-induced arthritis mouse model, weekly administration attenuates synovial inflammation, humoral autoimmune responses, bone erosion, and cartilage degradation while expanding Foxp3+ regulatory T cells. These findings establish self-dissociation-mediated size transformation as a functional materials strategy for lymph node-targeted antigen-specific immune tolerance and tolerogenic nanomedicine.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Dae-Duk Kim has the highest h-index among the authors (11).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (44)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 24 more references
A free account opens the rest of the citing papers and references on every paper’s page.